Keri Mattox

Keri Mattox

Chief Administrative Officer at ZIMMER BIOMET HOLDINGS, INC.

Health Technology
Consumer Services
Commercial Services

Profile

Keri P.
Mattox
currently works at Zimmer Biomet Holdings, Inc., as Chief Communications & Administrative Officer from 2022.
Ms. Mattox also formerly worked at Nabi Biopharmaceuticals, as Director-Investor Relations, FitzGerald Communications LLC, as Accounts Director, Cencora, Inc., as Vice President-Corporate & Investor Relations from 2017 to 2018, Auxilium Pharmaceuticals LLC, as SVP-Investor Relations & Corporate Communications, Endo International Plc, as SVP-Investor Relations & Corporate Affairs, Pure Communications, as Executive Vice President, and Real Chemistry, Inc., as Lead Integrated Communications.
Ms. Mattox received her undergraduate degree from Boston University and graduate degree from the University of Maryland.

Keri Mattox active positions

CompaniesPositionStart
ZIMMER BIOMET HOLDINGS, INC. Chief Administrative Officer 2022-05-25
All active positions of Keri Mattox

Former positions of Keri Mattox

CompaniesPositionEnd
CENCORA, INC. Investor Relations Contact 2018-05-31
AUXILIUM PHARMACEUTICALS, INC. Public Communications Contact 2015-01-28
Corporate Officer/Principal -
Comptroller/Controller/Auditor -
ENDO INTERNATIONAL PLC Investor Relations Contact -
See the detail of Keri Mattox's experience

Training of Keri Mattox

Boston University Undergraduate Degree
University of Maryland Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keri Mattox's experience

Connections

55

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ZIMMER BIOMET HOLDINGS, INC.

Health Technology

CENCORA, INC.

Distribution Services

Private companies6

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Technology Services

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW